Feline Bronchitis and Asthma: Welfare-Focused Management

Feline bronchitis causes chronic airway inflammation and acute bronchospasm episodes that are frightening and potentially life-threatening for cats.

Key Facts

• Feline bronchitis/asthma affects approximately 1-5% of cats, with Siamese at higher risk
• Acute bronchospasm causes distressing open-mouth breathing, neck extension, and panic
• Chronic airway inflammation causes airway remodeling and progressive respiratory compromise
• Inhaled corticosteroids are the preferred long-term treatment to minimize systemic side effects
• Environmental allergen reduction is an important adjunct to pharmaceutical management

Welfare Considerations

Feline bronchitis causes both chronic and acute welfare harms. During acute bronchospasm, cats experience acute respiratory distress — they crouch low, extend their neck, breathe with open mouth, and may panic as airway narrowing restricts oxygen delivery. These episodes are frightening and potentially fatal without prompt bronchodilator treatment. Chronically, ongoing airway inflammation causes reduced exercise tolerance, coughing, and wheezing that affects daily quality of life. Welfare-optimized management combines inhaled corticosteroids delivered via feline aerosol chamber (eliminating systemic steroid side effects) with a rescue bronchodilator for acute attacks, and environmental allergen minimization including no smoking, unscented litter, and HEPA filtration.

What You Can Do

• Train all household members to recognize acute asthma attacks and administer rescue bronchodilators
• Use an appropriately sized feline aerosol chamber to deliver inhaled medications effectively
• Eliminate household smoke, aerosols, scented candles, and dusty litter from the environment
• Perform regular rechecks including thoracic radiographs to monitor airway remodeling
• Learn to recognize early warning signs of worsening: increased respiratory rate, labored breathing at rest